Anlotinib Enhances the Therapeutic Effect of Bladder Cancer with GSDMB Expression: Analyzed from TCGA Bladder Cancer Database & Mouse Bladder Cancer Cell Line

INTRODUCTION AND OBJECTIVE: The mitogen-activated protein kinase (MAPK) pathway is inhibited by the pan-target inhibitor Anlotinib, which induces tumor cell death. In addition to the common apoptosis and necrosis, there is also a pyroptosis mode of cancer cell death in recent years, which is mainly...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chen, Cao, Qifeng, Zhang, Shun, Liu, Hailong, Duan, Huangqi, Xia, Weimin, Shen, Haibo, Wang, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029935/
https://www.ncbi.nlm.nih.gov/pubmed/36960215
http://dx.doi.org/10.2147/PGPM.S398451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029935/
https://www.ncbi.nlm.nih.gov/pubmed/36960215
http://dx.doi.org/10.2147/PGPM.S398451

Ejemplares similares